These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19601818)

  • 21. Controlled delivery systems: from pharmaceuticals to cells and genes.
    Balmayor ER; Azevedo HS; Reis RL
    Pharm Res; 2011 Jun; 28(6):1241-58. PubMed ID: 21424163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Applications of Natural Polymeric Materials in Solid Oral Modified-Release Dosage Forms.
    Li L; Zhang X; Gu X; Mao S
    Curr Pharm Des; 2015; 21(40):5854-67. PubMed ID: 26446465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymer-based carriers for ophthalmic drug delivery.
    Imperiale JC; Acosta GB; Sosnik A
    J Control Release; 2018 Sep; 285():106-141. PubMed ID: 29964135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug delivery to the central nervous system: a review.
    Misra A; Ganesh S; Shahiwala A; Shah SP
    J Pharm Pharm Sci; 2003; 6(2):252-73. PubMed ID: 12935438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategies to improve drug delivery across the blood-brain barrier.
    de Boer AG; Gaillard PJ
    Clin Pharmacokinet; 2007; 46(7):553-76. PubMed ID: 17596102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implantable and transdermal polymeric drug delivery technologies for the treatment of central nervous system disorders.
    Govender T; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Modi G; Naidoo D; Pillay V
    Pharm Dev Technol; 2017 Jun; 22(4):476-486. PubMed ID: 27268737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in drug delivery to the central nervous system by inhalation.
    Tai W; Kwok PCL
    Expert Opin Drug Deliv; 2022 May; 19(5):539-558. PubMed ID: 35532357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel methods of antiepileptic drug delivery -- polymer-based implants.
    Halliday AJ; Moulton SE; Wallace GG; Cook MJ
    Adv Drug Deliv Rev; 2012 Jul; 64(10):953-64. PubMed ID: 22564384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delivery of therapeutics to the central nervous system.
    Chambers JJ
    Adv Drug Deliv Rev; 2012 May; 64(7):589. PubMed ID: 22388004
    [No Abstract]   [Full Text] [Related]  

  • 30. Microglia--a therapeutic target in neurological diseases and disorders.
    Kaur C; Ling EA
    CNS Neurol Disord Drug Targets; 2013 Sep; 12(6):719. PubMed ID: 24047518
    [No Abstract]   [Full Text] [Related]  

  • 31. [Targeted nanomedicine in diagnostics and therapy of neurological diseases].
    Bertalan F; László B; Attila V
    Ideggyogy Sz; 2013 May; 66(5-6):155-63. PubMed ID: 23909015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CNS disorders--current treatment options and the prospects for advanced therapies.
    DiNunzio JC; Williams RO
    Drug Dev Ind Pharm; 2008 Nov; 34(11):1141-67. PubMed ID: 18720140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dendrimers as a promising tool in ocular therapeutics: Latest advances and perspectives.
    Rodríguez Villanueva J; Navarro MG; Rodríguez Villanueva L
    Int J Pharm; 2016 Sep; 511(1):359-366. PubMed ID: 27436708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperbranched polymer-drug conjugates with high drug payload for enhanced cellular delivery.
    Kolhe P; Khandare J; Pillai O; Kannan S; Lieh-Lai M; Kannan R
    Pharm Res; 2004 Dec; 21(12):2185-95. PubMed ID: 15648249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymer therapeutics-prospects for 21st century: the end of the beginning.
    Duncan R; Vicent MJ
    Adv Drug Deliv Rev; 2013 Jan; 65(1):60-70. PubMed ID: 22981753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancing oral absorption in animals.
    Crowley PJ; Martini LG
    Curr Opin Drug Discov Devel; 2001 Jan; 4(1):73-80. PubMed ID: 11727326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Photo-triggered Drug Delivery Systems for Neuron-related Applications.
    Li W; Lin J; Wang T; Huang P
    Curr Med Chem; 2019; 26(8):1406-1422. PubMed ID: 29932026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies for drug delivery to the central nervous system by systemic route.
    Kasinathan N; Jagani HV; Alex AT; Volety SM; Rao JV
    Drug Deliv; 2015 May; 22(3):243-57. PubMed ID: 24471801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting kinin receptors for the treatment of neurological diseases.
    Rodi D; Couture R; Ongali B; Simonato M
    Curr Pharm Des; 2005; 11(10):1313-26. PubMed ID: 15853687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of nanotechnology in developing new therapies for diseases of the nervous system.
    Jain KK
    Nanomedicine (Lond); 2006 Jun; 1(1):9-12. PubMed ID: 17716203
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.